Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in Kezar Life Sciences, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +5 vs. Q3 2025
- Shares held
- 4.46M
- +303.7K (+7.3%) vs. Q3 2025
- Total value
- $28.1M
- +$11.8M (+73.1%) vs. Q3 2025
- New holders
- 11
- 10 more added
- Sold out
- 6
- 17 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $6 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 40 | $252 | 0.00% | −316−88.8% | Reduced |
| Allworth Financial LP | 50 | $315 | 0.00% | +50 | New |
| BNP Paribas Arbitrage, SA | 89 | $560 | 0.00% | −7−7.3% | Reduced |
| Advisor Group Holdings, Inc. | 94 | $591 | 0.00% | +4+4.4% | Added |
| CIBC Private Wealth Group, LLC | 100 | $629 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 109 | $686 | 0.00% | −100−47.8% | Reduced |
| Bank of America Corp | 122 | $768 | 0.00% | +1+0.8% | Added |
| Royal Bank of Canada | 112 | $1.00K | 0.00% | +112 | New |
| FMR LLC | 208 | $1.31K | 0.00% | −8,524−97.6% | Reduced |
| Tower Research Capital LLC (TRC) | 564 | $3.55K | 0.00% | −623−52.5% | Reduced |
| Global Retirement Partners, LLC | 1,000 | $6.29K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,685 | $35.8K | 0.00% | −2,135−27.3% | Reduced |
| Wells Fargo & Company | 5,836 | $36.7K | 0.00% | −10−0.2% | Reduced |
| Two Sigma Investments, LP | 11,312 | $71.2K | 0.00% | −12,370−52.2% | Reduced |
| Northern Trust Corp | 13,763 | $86.6K | 0.00% | −177−1.3% | Reduced |
| Boothbay Fund Management, LLC | 16,210 | $102.0K | 0.00% | −4,690−22.4% | Reduced |
| Torno Capital, LLC | 20,000 | $125.8K | 0.05% | +20,000 | New |
| Nano Cap New Millennium Growth Fund L P | 25,000 | $157.3K | 0.13% | +25,000 | New |
| Dimensional Fund Advisors LP | 26,543 | $167.0K | 0.00% | +3,312+14.3% | Added |
| State Street Corp | 27,093 | $170.4K | 0.00% | +6,000+28.4% | Added |
| RBF Capital, LLC | 28,144 | $177.0K | 0.01% | −109−0.4% | Reduced |
| Shay Capital LLC | 33,699 | $212.0K | 0.03% | −33,962−50.2% | Reduced |
| Vazirani Asset Management LLC | 48,428 | $304.6K | 1.85% | +48,428 | New |
| FNY Investment Advisers, LLC | 50,000 | $314.0K | 0.09% | +50,000 | New |
| Bridgeway Capital Management, LLC | 51,638 | $324.8K | 0.01% | +10,638+25.9% | Added |
| Prelude Capital Management, LLC | 52,929 | $332.9K | 0.02% | +52,929 | New |
| Geode Capital Management, LLC | 68,167 | $428.9K | 0.00% | +2,665+4.1% | Added |
| Aldebaran Capital, LLC | 80,630 | $507.2K | 0.45% | +80,630 | New |
| Rangeley Capital, LLC | 85,926 | $540.5K | 0.47% | +85,926 | New |
| BlackRock, Inc. | 98,684 | $620.7K | 0.00% | +581+0.6% | Added |
| Ikarian Capital, LLC | 102,211 | $642.9K | 0.08% | −4,690−4.4% | Reduced |
| ADAR1 Capital Management, LLC | 117,440 | $738.7K | 0.06% | −7,527−6.0% | Reduced |
| Acadian Asset Management LLC | 125,371 | $787.0K | 0.00% | −8,154−6.1% | Reduced |
| Peapod Lane Capital LLC | 126,699 | $796.9K | 0.68% | +926+0.7% | Added |
| Renaissance Technologies LLC | 131,285 | $825.8K | 0.00% | +15,400+13.3% | Added |
| Stonepine Capital Management, LLC | 156,179 | $982.4K | 0.78% | −227,003−59.2% | Reduced |
| Affinity Asset Advisors, LLC | 229,076 | $1.44M | 0.10% | +229,076 | New |
| Nantahala Capital Management, LLC | 276,754 | $1.74M | 0.10% | +276,754 | New |
| Vanguard Group Inc | 341,404 | $2.15M | 0.00% | +73,238+27.3% | Added |
| Tang Capital Management LLC | 664,314 | $4.18M | 0.21% | −55,686−7.7% | Reduced |
| Suvretta Capital Management, LLC | 716,759 | $4.51M | 0.11% | 00.0% | Unchanged |
| BML Capital Management, LLC | 720,787 | $4.53M | 4.01% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −192,700−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −54,261−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −33,610−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,221−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −13,042−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| Qiming U.S. Ventures Management, LLC | – | – | – | – | Not filed |